Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Teva Pharmaceutical Industries, 5.125% 9may2029, USD (US88167AAQ40)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard
PDF download
Choose all Reset all
Download Cancel
Add issue to Watchlist
Choose all Reset all
{{ watchlistErrorMsg }}
Save Collapse
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.

Guaranteed, Variable rate, Trace-eligible, Sustainability Linked Bonds, Senior Unsecured

Status
Outstanding
Amount
1,000,000,000 USD
Placement
***
Redemption (put/call option)
*** (-)
ACI on
Country of risk
Israel
Current coupon
***%
Price
-
Yield / Duration
-
Reports of guarantors / borrowers / offerers
Guarantor Teva Pharmaceutical Industries
Reporting IFRS
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
  • Placement amount
    1,000,000,000 USD
  • Outstanding amount
    1,000,000,000 USD
  • USD equivalent
    1,000,000,000 USD
  • Minimum Settlement Amount
    200,000 USD
  • ISIN
    US88167AAQ40
  • CFI
    DBFGGR
  • FIGI
    BBG0136TNRY0
  • Ticker
    TEVA 5.125 05/09/29

Find Any Data on Any Bond in Just One Click

Full data on over 800,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Final Terms

Prospectus

Show all Hide
Authorization required
It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Quotes provided by information providers are indicative in nature

Issue information

Profile
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
Volume
  • Placement amount
    1,000,000,000 USD
  • Outstanding amount
    1,000,000,000 USD
  • Outstanding face value amount
    1,000,000,000 USD
Nominal
  • Minimum Settlement Amount
    200,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Variable rate type
    Rate change under special conditions
  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot
Export to Excel

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 800,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • The purpose of placing
    General Corporate Purposes Refinance
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***, ***, ***

Conversion and exchange

  • Conversion terms
    ***

Additional information

Latest issues

Show all

News

04/10/2023 Teva Pharmaceutical Industries: Regulation Fd Disclosure, Financial Statements And Exhibits
25/09/2023 Teva Pharmaceutical Industries: And Exhibit 99.1 Hereto Is Being Furnished To The Securities And Exchange Commission (the Commission ) And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ) Nor Shall It Be Deemed Incorporated By Reference In Any Filing Made By The Company Under The Securities Act Or The Exchange Act, Except As Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits
21/08/2023 Teva Pharmaceutical Industries: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
16/08/2023 Fitch Ratings affirms Teva Pharmaceutical Industries at "BB-" (LT Int. Scale (foreign curr.) credit rating); outlook stable
02/08/2023 Teva Pharmaceutical Industries: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
2016
IV q eng
2015
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Identifiers

  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBFGGR
  • FIGI
    BBG0136TNRY0
  • WKN
    A3KYRR
  • Ticker
    TEVA 5.125 05/09/29
  • Type of security by CBR
    ***

Ratings

Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Variable rate
  • Guaranteed
  • Sustainability Linked Bonds
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
Show more Hide

Restructuring

***

Holders

Registration is required to get access.